We are live on ! Find out more
ICM

ISZO Capital Management Portfolio holdings

AUM $2M
1-Year Est. Return 35.61%
This Fund
S&P 500
This Quarter Est. Return
-32.14%
1 Year Est. Return
+35.61%
3 Year Est. Return
+68.24%
5 Year Est. Return
+471.73%
10 Year Est. Return
AUM
$84.3M
AUM Growth
-$106M
Cap. Flow
-$90M
Cap. Flow %
-106.76%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
2
Reduced
2
Closed
3

Sector Composition

Rank Sector Weight
1 Real Estate 58.64%
2 Healthcare 41.36%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTP
1
DELISTED
Nam Tai Property Inc.
NTP
$45.1M 53.53%
7,219,372
+546,010
+8% +$4.5M
NOTV
2
DELISTED
Inotiv
NOTV
$25.2M 29.91%
264,598
-1,010,781
-79% -$28.4M
LFCR icon
3
Lifecore Biomedical
LFCR
$166M
$6.93M 8.22%
2,176,949
+251,638
+13% +$2.8M
CBL
4
CBL Properties
CBL
$1.82B
$4.31M 5.12%
+131,100
New +$3.79M
CCEL icon
5
Cryo-Cell International
CCEL
$27.6M
$2.73M 3.23%
357,107
-125,824
-26% -$1.16M
XPEL icon
6
XPEL
XPEL
$1.22B
-103,860
Closed -$7.09M
CDMO
7
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-2,208,313
Closed -$64.4M
CO
8
DELISTED
Global Cord Blood Corporation
CO
-1,000
Closed -$4K

Similar funds

ISZO Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, ISZO Capital Management held 8 positions worth $84.3M, down 56% from $190M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ISZO Capital Management withdrew a net $90M in Q1 2022, closing 3 positions and reducing 2 holdings. Its most notable exit was Avid Bioservices, Inc. Common Stock, an estimated $64.4M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, ISZO Capital Management opened a new position in CBL Properties worth $4.31M.

  • ISZO Capital Management's largest Q1 2022 buy was CBL Properties: 131,100 shares worth $4.31M.
  • ISZO Capital Management added most to Nam Tai Property Inc. in Q1 2022, an estimated $4.5M increase.
  • ISZO Capital Management's biggest Q1 2022 reduction was Inotiv, cutting an estimated $28.4M.
  • ISZO Capital Management fully exited Avid Bioservices, Inc. Common Stock in Q1 2022, selling an estimated $64.4M.
  • ISZO Capital Management's ten largest holdings make up 100% of its $84.3M portfolio in Q1 2022.
  • ISZO Capital Management opened 1 new position and closed 3 in Q1 2022.
  • ISZO Capital Management's portfolio value fell 56% quarter-over-quarter to $84.3M.

Based on ISZO Capital Management's 13F filing for Q1 2022, filed 16 May 2022.